|
|
| CAS番号. | 3466-82-8 |
| 化学名: | |
| 别名: | |
| 英語化学名: | 2-PHENYL-AZEPANE |
| 英語别名: | 2-PHENYL-AZEPANE;2-phenylazacycloheptane;2-Phenylperhydroazepine;2-Phenylhexahydroazepine;2-Phenyl-hexaMethyleniMine;Hexahydro-2-phenyl-1H-azepine;1H-Azepine,hexahydro-2-phenyl- |
| CBNumber: | CB6371436 |
| 分子式: | C12H17N |
| 分子量: | 175.27 |
| MOL File: | 3466-82-8.mol |
|
|
|
|
2-PHENYL-AZEPANE 化学特性,用途語,生産方法 |
使用
Can be used in the preparation of pyrrolylphenylsulfonates as dopamine D3 antagonists as well as in the preparation of substituted amidothiophene derivatives for use as 11-β-HSD1 inhibitors. |
|
|
| 2-PHENYL-AZEPANE 上流と下流の製品情報 |
原材料
|
準備製品
|
| 2-PHENYL-AZEPANE 生産企業 Global( 32)Suppliers |
| 名前 | 電話番号 | ファックス番号 | 電子メール | 国籍 | 製品カタログ | 優位度 |
|
J & K SCIENTIFIC LTD.
| -- | -- | jkinfo@jkchemical.com;market3@jkchemical.com | CHINA |
96847
|
76
|
|
JinYan Chemicals(ShangHai) Co.,Ltd.
| 13817811078,021-50426030 | 86-021-50426522,50426273 | sales@jingyan-chemical.com | CHINA |
10108
|
60
|
|
Nanjing Chemlin Chemical Co., Ltd
| 025-83697070; 010-68547217 | +86-25-83453306 | sales@chemlin.com.cn | CHINA |
20120
|
64
|
|
Chemsky (shanghai) International Co.,Ltd
| 021-50135380 | | shchemsky@sina.com | CHINA |
15730
|
60
|
|
Lanzhou Agli Biochemical Technology Co., Ltd.
| +86 (943) 853-5351 | +86 (943) 853-5351 | aglichem-lqs@aglichem.com | CHINA |
2526
|
60
|
|
T&W GROUP
| +86-21-61551611, 61551413, 61551420, 61551610 | +86-21-50676805 | contact@trustwe.com | CHINA |
13395
|
58
|
|
Beijing Kaida Technology Development Co., Ltd.
| +86 (10) 5664-5598 / +86 13811060439 | +86 (10) 62230033 | bjkaida@163.com | CHINA |
2000
|
59
|
|
Shanghai Jian Chao Chemical Technology Co., Ltd.
| 021-31252569;18016036736;qq 1849315414 | 021-51632682 | lyh_antaeus@163.com | CHINA |
5010
|
55
|
|
shanghai cooperpharm co.,LTD .
| +86-021-58975553 | +86-021-58975554 | sales@cooperpharm.com | CHINA |
1210
|
56
|
|
Shanghai Dano Pharmaceutical Co., LTD(China)
| (86)0592-6266840 (86)15750707980 | (86)0592-6266840 | sales@chemdano.com | CHINA |
1705
|
57
|
|
|
|
|